Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2015 (2015), Article ID 701979, 12 pages
http://dx.doi.org/10.1155/2015/701979
Research Article

Development of Polymeric Nanoparticles of Garcinia mangostana Xanthones in Eudragit RL100/RS100 for Anti-Colon Cancer Drug Delivery

1Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden Barracks, Pulau Pinang, Malaysia
2Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden Barracks, Pulau Pinang, Malaysia
3Chair of “Medical Applications of Nanomaterials”, King Abdullah Institute for Nanotechnology, King Saud University, Riyadh 11451, Saudi Arabia
4Nanomedicine Section, King Abdullah International Medical Research Center, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia

Received 25 May 2015; Revised 12 September 2015; Accepted 5 October 2015

Academic Editor: Ilaria Armentano

Copyright © 2015 Abdalrahim F. A. Aisha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Akao, Y. Nakagawa, M. Iinuma, and Y. Nozawa, “Anti-cancer effects of xanthones from pericarps of mangosteen,” International Journal of Molecular Sciences, vol. 9, no. 3, pp. 355–370, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Pedraza-Chaverri, N. Cárdenas-Rodríguez, M. Orozco-Ibarra, and J. M. Pérez-Rojas, “Medicinal properties of mangosteen (Garcinia mangostana),” Food and Chemical Toxicology, vol. 46, no. 10, pp. 3227–3239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Obolskiy, I. Pischel, N. Siriwatanametanon, and M. Heinrich, “Garcinia mangostana L.: a phytochemical and pharmacological review,” Phytotherapy Research, vol. 23, no. 8, pp. 1047–1065, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Matsumoto, Y. Akao, H. Yi et al., “Preferential target is mitochondria in alpha-mangostin-induced apoptosis in human leukemia HL60 cells,” Bioorganic and Medicinal Chemistry, vol. 12, no. 22, pp. 5799–5806, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Doi, M.-A. Shibata, E. Shibata et al., “Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer,” Anticancer Research, vol. 29, no. 7, pp. 2485–2495, 2009. View at Google Scholar · View at Scopus
  6. S.-H. Hung, K.-H. Shen, C.-H. Wu, C.-L. Liu, and Y.-W. Shih, “α-mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway,” Journal of Agricultural and Food Chemistry, vol. 57, no. 4, pp. 1291–1298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-H. Yoo, K. Kang, E. H. Jho, Y.-W. Chin, J. Kim, and C. W. Nho, “α- and γ-Mangostin inhibit the proliferation of colon cancer cells via β-catenin gene regulation in Wnt/cGMP signalling,” Food Chemistry, vol. 129, no. 4, pp. 1559–1566, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Tewtrakul, C. Wattanapiromsakul, and W. Mahabusarakam, “Effects of compounds from Garcinia mangostana on inflammatory mediators in RAW264.7 macrophage cells,” Journal of Ethnopharmacology, vol. 121, no. 3, pp. 379–382, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L.-G. Chen, L.-L. Yang, and C.-C. Wang, “Anti-inflammatory activity of mangostins from Garcinia mangostana,” Food and Chemical Toxicology, vol. 46, no. 2, pp. 688–693, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Sakagami, M. Iinuma, K. G. N. P. Piyasena, and H. R. W. Dharmaratne, “Antibacterial activity of α-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics,” Phytomedicine, vol. 12, no. 3, pp. 203–208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Suksamrarn, N. Suwannapoch, W. Phakhodee et al., “Antimycobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana,” Chemical and Pharmaceutical Bulletin, vol. 51, no. 7, pp. 857–859, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. P. D. Sampath and K. Vijayaraghavan, “Cardioprotective effect of α-mangostin, a xanthone derivative from Mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats,” Journal of Biochemical and Molecular Toxicology, vol. 21, no. 6, pp. 336–339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Cui, W. Hu, Z. Cai et al., “New medicinal properties of mangostins: analgesic activity and pharmacological characterization of active ingredients from the fruit hull of Garcinia mangostana L.,” Pharmacology Biochemistry and Behavior, vol. 95, no. 2, pp. 166–172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H.-A. Jung, B.-N. Su, W. J. Keller, R. G. Mehta, and A. D. Kinghorn, “Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen),” Journal of Agricultural and Food Chemistry, vol. 54, no. 6, pp. 2077–2082, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-P. Tang, P.-G. Li, M. Kondo, H.-P. Ji, Y. Kou, and B. Ou, “Effect of a mangosteen dietary supplement on human immune function: a randomized, double-blind, placebo-controlled trial,” Journal of Medicinal Food, vol. 12, no. 4, pp. 755–763, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Yu, M. Zhao, B. Yang, and W. Bai, “Immunomodulatory and anticancer activities of phenolics from Garcinia mangostana fruit pericarp,” Food Chemistry, vol. 116, no. 4, pp. 969–973, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. F. A. Aisha, K. M. Abu-Salah, Z. Ismail, and A. Majid, “In vitro and in vivo anti-colon cancer effects of Garcinia mangostana xanthones extract,” BMC Complementary and Alternative Medicine, vol. 12, article 104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Li, I. Brunner, A.-R. Han et al., “Pharmacokinetics of alpha-mangostin in rats after intravenous and oral application,” Molecular Nutrition and Food Research, vol. 55, supplement 1, pp. S67–S74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Ubrich, C. Schmidt, R. Bodmeier, M. Hoffman, and P. Maincent, “Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles,” International Journal of Pharmaceutics, vol. 288, no. 1, pp. 169–175, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Lopedota, A. Trapani, A. Cutrignelli et al., “The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 72, no. 3, pp. 509–520, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Pignatello, C. Bucolo, P. Ferrara, A. Maltese, A. Puleo, and G. Puglisi, “Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen,” European Journal of Pharmaceutical Sciences, vol. 16, no. 1-2, pp. 53–61, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Dong, C. A. Mattingly, M. T. Tseng et al., “Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP,” Cancer Research, vol. 69, no. 9, pp. 3918–3926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. OECD, OECD 105 Guidelines for the Testing of Chemicals, Water Solubility, Organization for Economic Cooperation & Development, Paris, France, 1995.
  24. H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, “Nanocapsule formation by interfacial polymer deposition following solvent displacement,” International Journal of Pharmaceutics, vol. 55, no. 1, pp. R1–R4, 1989. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Sameti, G. Bohr, M. N. V. Ravi Kumar et al., “Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery,” International Journal of Pharmaceutics, vol. 266, no. 1-2, pp. 51–60, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. E. L. McConnell, H. M. Fadda, and A. W. Basit, “Gut instincts: explorations in intestinal physiology and drug delivery,” International Journal of Pharmaceutics, vol. 364, no. 2, pp. 213–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Rajput, I. Dominguez San Martin, R. Rose et al., “Characterization of HCT116 human colon cancer cells in an orthotopic model,” Journal of Surgical Research, vol. 147, no. 2, pp. 276–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. F. A. Aisha, Z. Ismail, K. M. Abu-salah, and A. M. S. A. Majid, “Solid dispersions of α-mangostin improve its aqueous solubility through self-assembly of nanomicelles,” Journal of Pharmaceutical Sciences, vol. 101, no. 2, pp. 815–825, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. L. M. Jost, J. M. Kirkwood, and T. L. Whiteside, “Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells,” Journal of Immunological Methods, vol. 147, no. 2, pp. 153–165, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. U. Bilati, E. Allémann, and E. Doelker, “Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles,” European Journal of Pharmaceutical Sciences, vol. 24, no. 1, pp. 67–75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. De Chasteigner, G. Cavé, H. Fessi, J.-P. Devissaguet, and F. Puisieux, “Freeze-drying of itraconazole-loaded nanosphere suspensions: a feasibility study,” Drug Development Research, vol. 38, no. 2, pp. 116–124, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Lee, C.-H. Ahn, and T. G. Park, “Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin,” Macromolecular Bioscience, vol. 9, no. 4, pp. 336–342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. K. T. Thurn, H. Arora, T. Paunesku et al., “Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 7, no. 2, pp. 123–130, 2011. View at Publisher · View at Google Scholar · View at Scopus